The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
1 other identifier
observational
648
14 countries
15
Brief Summary
This is an international multicenter prospective observational study. Patients with radiologically confirmed, symptomatic, single- or multilevel contiguous TL (from T1 to L5) fractures as a result of primary osteoporosis will be recruited from participating clinics/hospitals (ie, study sites). Fractures included are insufficiency fractures (confirmed by magnetic resonance imaging \[MRI\]) and traumatic fractures (low-energy trauma, confirmed by computed tomography \[CT\] or MRI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2026
Longer than P75 for all trials
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2025
CompletedFirst Posted
Study publicly available on registry
June 18, 2025
CompletedStudy Start
First participant enrolled
March 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
February 25, 2026
February 1, 2026
2.7 years
May 2, 2025
February 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Return to mobility
Determination in patients with symptomatic osteoporotic TL fractures whether an initial treatment adhering to the OF score recommendations (the Accordance group) generates better short-term patient outcomes regarding time to return to mobility level before injury or symptom onset within 3 months after treatment compared to an initial treatment decision not adhering to the OF score recommendations (the Discordance group). The primary outcome of the study is return to the mobility level. Patients will be instructed to evaluate their overall mobility level in reference to their pre-injury or pre-symptom mobility status. This primary outcome will be reported by the patient and measured on a continuous scale of 0 to 100 (0 = no return at all, 100 = full return). Primary endpoint of the study is the time (days) to return of pre-injury or pre-symptom mobility level within 3 months after Day 0. Threshold of returning is defined as ≥ 80 on the continuous scale.
From day of treatment to the end of the first 3 months after treatment.
Secondary Outcomes (19)
Comparison of return to mobility (categorical scale)
At all predefined visits from discharge to 12months post treatment
Comparison of the extent of return to mobility
3 months post-operative and 12-months postoperative
Comparison of clinical outcome
3 months post-operative and 12-months postoperative
Comparison of the proportion return to mobility
3 months post-operative and 12-months postoperative
Comparison of Timed Up & Go test
3 months post-operative and 12-months postoperative
- +14 more secondary outcomes
Study Arms (2)
OF score accordance group
Initial treatment decision in accordance with the OF score recommendations
OF score discordance group
Initial treatment decision in discordance with the OF score recommendations
Interventions
* Any other type of solely vertebral augmentation (stents, etc.), specify * Posterior stabilization (pedicle screws) * Posterior stabilization (pedicle screws) with kyphoplasty/vertebroplasty * Posterior stabilization (pedicle screws) with screw augmentation * Posterior stabilization (pedicle screws) with screw augmentation and kyphoplasty/vertebroplasty * Posterior stabilization (pedicle screws) with vertebral osteotomy (pedicle subtraction osteotomy or similar) * Combined posterior and anterior stabilization
Eligibility Criteria
Postmenopausal women ≥ 50 years old or men \> 60 years old
You may qualify if:
- Postmenopausal women ≥ 50 years old or men \> 60 years old
- o Menopause refers to amenorrhea for 1 complete year.
- Radiologically confirmed new diagnosis of symptomatic, single or multilevel TL (from T1 to L5) fractures, ie, the index fracture(s).
- In case of a multilevel fracture, the fracture must be contiguous.
- The index fracture is confirmed by MRI as an insufficiency (or fragility) fracture or is confirmed by CT or MRI as traumatic fracture (low-energy trauma)
- The index fracture(s) is a result of primary osteoporosis. Diagnosis of primary osteoporosis is based on any of the followings in the absence of causes for secondary osteoporosis (such as long-term use of steroids, rheumatoid arthritis, type 1 diabetes mellitus \[DM\], and other metabolic bone disorders \[eg, rickets/osteomalacia, Paget's disease, osteogenesis imperfecta, and primary hyperparathyroidism\]) \[13-15\]:
- A T-score ≤ -2.5 in the lumbar spine, femoral neck, total hip, or 1/3 radius
- Presence of fragility fracture (either a previous fragility fracture or the index fracture is a fragility fracture). Fragility fractures are fractures due to no or low-energy trauma, eg, slips, trips, or falls from less than double the body height, and heavy lifting.
- The index osteoporotic TL fracture being classified based on the OF Classification from OF 1 to OF 5:
- OF 1: No deformation (vertebral body edema on MRI using short tau inversion recovery \[STIR\] sequence)
- OF 2: Deformation of one endplate
- OF 3: Deformation of one endplate with distinct posterior wall involvement
- OF 4: Deformation of both endplates with/without posterior wall involvement
- OF 5: Injuries with anterior or posterior tension band failure
- Ability to provide informed consent according to the EC/IRB defined and approved procedures
You may not qualify if:
- Patients with spinal tumors
- Patients with concomitant cervical fractures
- Patients showing any signs of spinal infections
- Patients with fractures due to high-energy or high-impact trauma, eg, a fall from double the body height or higher, motor vehicle accident with \> 100 km/h in cars with airbags, or motor vehicle accident \> 50 km/h without airbags, polytrauma
- Patients with concomitant fracture in the pelvis, upper extremities, and/or lower extremities which could affect the main study outcomes (specifically, patient mobility and pain)
- Patients for whom no FUs are possible
- Previous instrumented surgery in the affected spine levels
- Patients with single-level fracture or contiguous multilevel fracture adjacent to previous instrumented surgery
- Patients who are mentally impaired and therefore not able to adhere to the study procedures and data collection
- Patients who are bedridden before the index fracture
- Recent history of substance abuse (ie, recreational drugs and alcohol) that would preclude reliable assessments
- Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (15)
University of California San Francisco (USCF) Department of Orthopaedic Surgery
San Francisco, California, 94143-0728, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107-4216, United States
Sanatorio Güemes
Buenos Aires, 1240, Argentina
Cajuru University Hospital
Curitiba, 80050-50, Brazil
Department of Orthopedic Surgery, Clinica Alemana de Santiago
Santiago, 5951, Chile
Orthopaedic Department, Assiut University Hospitals, Faculty of Medicine
Asyut, 71526, Egypt
Tampere University Hospital
Tampere, 33521, Finland
Center for Spinal and Scoliosis Surgery, Malteser Waldkrankenhaus St. Marien
Erlangen, 91054, Germany
PGIMER - Postgraduate Institute of Medical Education and Research
Chandigarh, 160 012, India
Dokkyo Medical University Hospital
Tochigi, 321-0293, Japan
Island Hospital Spine Centre
George Town, 10450, Malaysia
Spiatlul Clinic De Urgenta, "Profesor Doctor Nicolae Oblu"
Iași, 700309, Romania
Security Force Hospital
Riyāḑ, 11564, Saudi Arabia
Spital Emmental - Orthopädie Sonnenhof
Burgdorf, 3400, Switzerland
King's College Hospital
London, SE5 9RS, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Klaus Schnake, MD
Center for Spinal and Scoliosis Surgery
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2025
First Posted
June 18, 2025
Study Start
March 10, 2026
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2030
Last Updated
February 25, 2026
Record last verified: 2026-02